Skip to main content

Menopausal Hormone Therapy (MHT) discontinuation and shortages January 2025

Australia 

Patch Shortages

There are a number of MHTs that are currently unavailable. Please note that the TGA has approved some unregistered products under Section 19A and some substitute doses are currently in supply in Australia. Pharmacists are encouraged to contact suppliers Medsurge Healthcare Pty Ltd on 1300 788 261 for orders of Estramon and Sandoz on 1800 726 369 for orders of Estradiol Transdermal System.

Oestradiol patches

 

Availability and expected supply due

Alternative supply under Section 19A

Dose

Estradot

Estraderm

Estramon

Estradiol Transdermal System

25 mcg

Unavailable - 31 Dec 2025

Limited - 30th June 2025

Available

 

37.5 mcg

Unavailable - 30 Jun 2025

 

Available

Available

50 mcg

Unavailable - 31 Dec 2025

Limited - 30th June 2025

Available

Unavailable

75 mcg

Unavailable - 31 Dec 2025

Limited - 7 Feb 2025

Available

Unavailable

100 mcg

Unavailable - 31 Dec 2025

Limited - 7 April 2025

Available

Available

Combined patches

Dose

Estalis Sequi

Estalis Conti

50/140

Limited – 30 June 2025

Limited – 30 June 2025

50/250

Limited – 30 June 2025

Limited – 30 June 2025

All doses of Climara have been deleted from the market and there will be a reduction in supply until supply is exhausted.

The AMS Guide to MHT Doses (Australia only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in Australia.

New Zealand

As at 11 December 2024, patch availability is provided below.

Dose

Estradot

Viatris

Estraderm MX

25mcg

Limited

Available 

Available

50mcg

Limited

Available

 

75mcg

Limited

Available

 

100mcg

Limited

Available

 

More information can be found here  

The AMS Guide to MHT Doses (New Zealand only) provides a guideline to approximately equivalent doses of the different MHT/HRT products in New Zealand.